Almas Sadia, Carpenter Rob E, Tamrakar Vaibhav K, Sharma Aditya, Suri Kamalpreet, Karki Salima, Kyser Katelyn, Sronce Randy, Sharma Rahul
Department of Research, Scienetix, Tyler, Texas 75703, USA.
The University of Texas at Tyler, Tyler, Texas 75799, USA; Department of Research, Advanta Genetics, Tyler, Texas 75703, USA.
Diagn Microbiol Infect Dis. 2025 Oct;113(2):116923. doi: 10.1016/j.diagmicrobio.2025.116923. Epub 2025 May 22.
Fungal infections are an escalating health threat, and delays from conventional nucleic acid extraction hinder timely diagnosis and treatment. This study evaluated the diagnostic performance of a novel extraction-free technology, Direct-to-PCR (D2P; Scienetix, Tyler, TX, USA), for the detection of clinically significant Candida species (C. albicans, C. glabrata, C. auris, C. parapsilosis, and C. tropicalis). D2P was compared against conventional silica column-based (Qiagen) and magnetic bead-based (KingFisher) extraction methods, using microbial reference isolates, residual clinical specimens, and limit-of-detection analyses. Diagnostic sensitivity and specificity of D2P were comparable to conventional approaches, with specificity ranging from 96.77 % to 100 %. Concordance between methods was high, with Cohen's kappa coefficients (κ=0.93-1.00). Limit-of-detection analyses demonstrated strong analytical sensitivity, with excellent linearity (R²=0.924-0.999) and low replicate variability (coefficient of variation 0.2-6.3 %). Statistical comparison of cycle threshold values revealed no significant differences between methods (p > 0.05), supporting equivalent nucleic acid recovery without the need for time-intensive extraction steps. Despite these strengths, the study has limitations. The relatively small number of residual clinical specimens (n = 40) may restrict the generalizability of findings, and further validation across broader patient populations, specimen types, and clinical settings is warranted. Nevertheless, D2P offers a streamlined, rapid diagnostic workflow that reduces turnaround times and enhances accessibility, particularly in resource-limited environments. Wider adoption of extraction-free PCR platforms such as D2P could facilitate earlier detection of invasive candidiasis, improve clinical outcomes, and mitigate healthcare-associated morbidity and mortality attributable to fungal infections.
真菌感染对健康的威胁日益严重,传统核酸提取方法的耗时会妨碍及时诊断和治疗。本研究评估了一种新型免提取技术——直接PCR(D2P;美国得克萨斯州泰勒市的Scienetix公司)对临床上重要念珠菌属物种(白色念珠菌、光滑念珠菌、耳念珠菌、近平滑念珠菌和热带念珠菌)的检测性能。使用微生物参考菌株、剩余临床标本以及检测限分析,将D2P与传统的基于硅胶柱(Qiagen)和基于磁珠(KingFisher)的提取方法进行比较。D2P的诊断敏感性和特异性与传统方法相当,特异性范围为96.77%至100%。方法之间的一致性很高,科恩kappa系数(κ=0.93 - 1.00)。检测限分析显示出很强的分析灵敏度,具有出色的线性(R²=0.924 - 0.999)和低重复变异性(变异系数0.2 - 6.3%)。循环阈值的统计比较显示方法之间无显著差异(p>0.05),支持无需耗时提取步骤即可实现等效核酸回收。尽管有这些优点,但该研究仍有局限性。剩余临床标本数量相对较少(n = 40)可能会限制研究结果的普遍性,有必要在更广泛的患者群体、标本类型和临床环境中进行进一步验证。尽管如此,D2P提供了一种简化、快速的诊断流程,可减少周转时间并提高可及性,特别是在资源有限的环境中。更广泛地采用诸如D2P这样的免提取PCR平台可以促进侵袭性念珠菌病的早期检测,改善临床结果,并减轻与真菌感染相关的医疗相关发病率和死亡率。